Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2
Rudraraju, R.; Gartner, M. J.; Neil, J. A.; Stout, E. S.; Chen, J.; Needham, E. J.; See, M.; Mackenzie-Kludas, C.; Yang, L. Y.; Wang, M.; Pointer, H.; Karavendzas, K.; Abu-Bonsrah, D.; Drew, D.; Sun, Y. B. Y.; Tan, J. P.; Sun, G.; Salavaty, A.; Charitakis, N.; Nim, H. T.; Currie, P. D.; Tham, W.-H.; Porrello, E.; Polo, J.; Humphrey, S. J.; Ramialison, M.; Elliott, D. A.; Subbarao, K.
Show abstract
SARS-CoV-2 primarily infects the respiratory tract, but pulmonary and cardiac complications occur in severe COVID-19. To elucidate molecular mechanisms in the lung and heart, we conducted paired experiments in human stem cell-derived lung alveolar type II (AT2) epithelial cell and cardiac cultures infected with SARS-CoV-2. With CRISPR- Cas9 mediated knock-out of ACE2, we demonstrated that angiotensin converting enzyme 2 (ACE2) was essential for SARS-CoV-2 infection of both cell types but further processing in lung cells required TMPRSS2 while cardiac cells required the endosomal pathway. Host responses were significantly different; transcriptome profiling and phosphoproteomics responses depended strongly on the cell type. We identified several antiviral compounds with distinct antiviral and toxicity profiles in lung AT2 and cardiac cells, highlighting the importance of using several relevant cell types for evaluation of antiviral drugs. Our data provide new insights into rational drug combinations for effective treatment of a virus that affects multiple organ systems. One-sentence summaryRational treatment strategies for SARS-CoV-2 derived from human PSC models
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identification of SARS-CoV2-mediated suppression of NRF2 signaling reveals a potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate 94%
- A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity 93%
- Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology 93%
Similar papers in this journal
- Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread 93%
- Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases 92%
- AZD7442 demonstrates prophylactic and therapeutic efficacy in non-human primates and extended half-life in humans 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.